Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain

被引:65
作者
Pennington, MW
Mahnir, VM
Krafte, DS
Zaydenberg, I
Byrnes, ME
Khaytin, I
Crowley, K
Kem, WR
机构
[1] UNIV FLORIDA, COLL MED, DEPT PHARMACOL & THERAPEUT, GAINESVILLE, FL 32610 USA
[2] BOEHRINGER INGELHEIM PHARMACEUT INC, IMMUNOL DIS DEPT, RIDGEFIELD, CT 06877 USA
关键词
D O I
10.1006/bbrc.1996.0297
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eighteen synthetic analogs of ShK toxin, a thirty-five-residue K channel blocker derived from the sea anemone Stichodactyla helianthus, were prepared in order to identify functionally important residues. CD spectra of sixteen of the analogs were virtually identical with the spectrum of wild-type toxin, indicating that the conformations were not affected by the substitutions. A conserved residue, Lys22, is essential for ShK binding to rat brain K channels which are primarily of the Kv1.2 type. However, a cationic side chain at position 22 is nor essential for binding to the human Jurkat T-lymphocyte Kv1.3 channel. While decreasing bulkiness at this position affected toxin affinity for the brain K channels, increasing bulkiness decreased toxin affinity for both brain and lymphocyte K channels. In contrast to the rat brain channels, ShK; binding to Kv1.3 was sensitive to substitution at Lys9 and Arg11. (C) 1996 Academic Press, Inc.
引用
收藏
页码:696 / 701
页数:6
相关论文
共 18 条
  • [1] TOPOLOGY OF THE PORE-REGION OF A K+ CHANNEL REVEALED BY THE NMR-DERIVED STRUCTURES OF SCORPION TOXINS
    AIYAR, J
    WITHKA, JM
    RIZZI, JP
    SINGLETON, DH
    ANDREWS, GC
    LIN, W
    BOYD, J
    HANSON, DC
    SIMON, M
    DETHLEFS, B
    LEE, CL
    HALL, JE
    GUTMAN, GA
    CHANDY, KG
    [J]. NEURON, 1995, 15 (05) : 1169 - 1181
  • [2] A POTASSIUM CHANNEL TOXIN FROM THE SECRETION OF THE SEA-ANEMONE BUNODOSOMA-GRANULIFERA - ISOLATION, AMINO-ACID-SEQUENCE AND BIOLOGICAL-ACTIVITY
    ANEIROS, A
    GARCIA, I
    MARTINEZ, JR
    HARVEY, AL
    ANDERSON, AJ
    MARSHALL, DL
    ENGSTROM, A
    HELLMAN, U
    KARLSSON, E
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1157 (01) : 86 - 92
  • [3] BOTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756
  • [4] CASTANEDA O, 1995, TOXICON, V33, P606
  • [5] GUY HR, 1994, SOC GEN PHY, V49, P197
  • [6] HILL RJ, 1995, MOL PHARMACOL, V48, P98
  • [7] KARLSSON E, 1991, BR J PHARM, V104
  • [8] KARLSSON E, 1992, RECENT ADV TOXINOLOG, V2, P378
  • [9] KEM WR, 1996, IN PRESS LETT PEPTID, V2
  • [10] KIM JI, 1995, PEPTIDES 1994, P135